Investor Overview

Who is Organovo?
  • We participate in attractive and growing markets with critical unmet needs
  • We benefit from favorable competitive dynamics and a first mover advantage
  • We’re a technology leader with a strong IP portfolio
  • We’re leveraging our technology platform to build a robust product and service platform across the preclinical safety, efficacy and disease modeling and therapeutic tissues markets
2016 Annual Report Investor Fact Sheet Investor Presentation

Stock Information
ONVO (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) + 0.08 (2.77%)
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: ONVO.O.  Currently trading at $2.97 with a 52 week high of $4.99 and a 52 week low of $2.00.
Recent Investor News
Organovo Announces Fiscal Third-Quarter 2017 Results; Company Updates Full-Year Fiscal 2017 Total Revenue Outlook
Organovo Collaborates With Professor Melissa Little for Kidney Tissue Research
Investor Events
Wednesday, March 1, 2017
2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference
Featured Reports
2016 Annual Report
2016 Proxy Statement
Latest Tweets
Print Page Print Page | E-mail Page Email Page | RSS Feeds RSS Feeds | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet